---
title: "AIM ImmunoTech signed an agreement with PPD for a Phase 3 trial of Ampligen for late-stage pancreatic cancer treatment."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277481468.md"
description: "In a press release dated March 2nd, 2026, AIM ImmunoTech Inc. disclosed a partnership with the PPD™ clinical research unit of Thermo Fisher Scientific to develop a Phase 3 clinical trial for their drug Ampligen. This trial aims to explore the efficacy of Ampligen in treating advanced pancreatic cancer. AIM ImmunoTech Inc., listed on the NYSE American as AIM, is undertaking this collaboration to advance their research efforts in this critical area of oncology."
datetime: "2026-03-02T14:01:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277481468.md)
  - [en](https://longbridge.com/en/news/277481468.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277481468.md)
---

# AIM ImmunoTech signed an agreement with PPD for a Phase 3 trial of Ampligen for late-stage pancreatic cancer treatment.

In a press release dated March 2nd, 2026, AIM ImmunoTech Inc. disclosed a partnership with the PPD™ clinical research unit of Thermo Fisher Scientific to develop a Phase 3 clinical trial for their drug Ampligen. This trial aims to explore the efficacy of Ampligen in treating advanced pancreatic cancer. AIM ImmunoTech Inc., listed on the NYSE American as AIM, is undertaking this collaboration to advance their research efforts in this critical area of oncology.

### Related Stocks

- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [TMO.US](https://longbridge.com/en/quote/TMO.US.md)
- [AIM.US](https://longbridge.com/en/quote/AIM.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

- [Thermo Fisher Scientific and Precision Health Research Singapore Enter Strategic Collaboration to Advance Precise-SG100K Study](https://longbridge.com/en/news/282231224.md)
- [Is Thermo Fisher (TMO) Quietly Rewiring Its AI Strategy Through New Data and Proteomics Alliances?](https://longbridge.com/en/news/282768343.md)
- [Pancreatic cancer pill shown to nearly double overall survival time, drug company says](https://longbridge.com/en/news/282687539.md)
- [BUZZ-Street View: Analysts upbeat on Revolution pancreatic cancer drug](https://longbridge.com/en/news/282702171.md)
- [Revolution Medicines Says Daraxonrasib Shows Improvement In Survival In Late-Stage Pancreatic Cancer Study](https://longbridge.com/en/news/282550417.md)